Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Fuji
Federal Trade Commission
Covington
Dow
Baxter
Daiichi Sankyo
Deloitte
Boehringer Ingelheim

Generated: May 25, 2018

DrugPatentWatch Database Preview

VERSAPEN-K Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Versapen-k, and what generic alternatives are available?

Versapen-k is a drug marketed by Bristol and is included in one NDA.

The generic ingredient in VERSAPEN-K is hetacillin potassium. There are six drug master file entries for this compound. Additional details are available on the hetacillin potassium profile page.
Summary for VERSAPEN-K
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 24
Patent Applications: 1,589
DailyMed Link:VERSAPEN-K at DailyMed
Drug patent expirations by year for VERSAPEN-K
Synonyms for VERSAPEN-K
(2S,%R,6R)-6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptan-2-carbonsaeure
(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
26939-80-0
3511-16-8
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, (2S-(2alpha,5alpha,6beta(S*)))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-, monopotassium salt, (2S-(2alpha,5alpha,6beta(S*)))-
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2,2-dimethyl-5-oxo-4-phenyl-imidazolinyl)-3,3-dimethyl-7-oxo-, monopotassium salt
4052-56-6
5321-32-4
6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
6-(2,2-Dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)penicillansaeure
6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-2,2-dimethylpenam-3alpha-carboxylate
6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-2,2-dimethylpenam-3alpha-carboxylic acid
6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanate
6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid
7-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-6-oxo-2-thia-5-azabicyclo[3.2.0]heptane-4-carboxylic acid
95PFX5932Y
AC1L9EKH
AKOS027381814
AKOS030526838
BDBM50103615
BL-P 804
BL-P-804
BRL 804
BRL-804
C-23897
C11729
C13980
CC-29245
CHEBI:34789
CHEBI:52059
CHEBI:5683
CHEMBL1201116
CHEMBL1201121
CS-4870
CS-4871
D01074
D02203
DB00739
DR002253
DXVUYOAEDJXBPY-NFFDBFGFSA-N
EINECS 222-512-5
EINECS 226-182-3
etacillin
Etacillina
Etacillina [DCIT]
FT-0771485
H-K Mastitis (Veterinary)
HE337458
Hetacilina
Hetacilina [INN-Spanish]
hetacillin
Hetacillin (potassium)
Hetacillin (USAN/INN)
Hetacillin [USAN:USP:INN:BAN]
HETACILLIN POTASSIUM
Hetacillin potassium (JAN/USAN)
Hetacillin potassium [USAN:USP:JAN]
hetacillin(1-)
Hetacilline
Hetacilline [INN-French]
Hetacillinum
Hetacillinum [INN-Latin]
Hetacin-k (TN)
Hetacin-K (Veterinary)
HY-16251
HY-16251A
N,N'-Isopropylidene-A-amino-benzyl penicillin
N.N'-Isopropylidene-A-amino-benzyl penicillin
Natacillin
penplenum
Phenazacillin
Potassium (2S-(2alpha,5alpha,6beta(S*)))-6-(2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
potassium (2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Potassium 6-(2,2-dimethyl-5-oxo-4-phenyl-1-imidazolidinyl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
potassium 6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-2,2-dimethylpenam-3alpha-carboxylate
potassium 6beta-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanate
SCHEMBL192601
SCHEMBL34131
TN4JSC48CV
UNII-95PFX5932Y
UNII-TN4JSC48CV
Versapen
Versapen (TN)
ZINC4102186

US Patents and Regulatory Information for VERSAPEN-K

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol VERSAPEN-K hetacillin potassium CAPSULE;ORAL 061396-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol VERSAPEN-K hetacillin potassium CAPSULE;ORAL 061396-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fuji
Merck
US Department of Justice
Citi
Accenture
Deloitte
Cantor Fitzgerald
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.